Status:
COMPLETED
Prophylactic Tranexamic Acid Use After Vaginal Delivery
Lead Sponsor:
Sanliurfa Mehmet Akif Inan Education and Research Hospital
Collaborating Sponsors:
Sisli Hamidiye Etfal Training and Research Hospital
Conditions:
Postpartum Hemorrhage
Vaginal Delivery
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
In this study, our aim was to evaluate the effectiveness of prophylactic tranexamic acid use after vaginal delivery in pregnant women aged 18-45 years and 34-42 weeks according to the risk of postpart...
Detailed Description
It was carried out as a double-blind prospective randomized controlled Phase 4 drug study with 480 singleton pregnant women in Bursa Yüksek İhtisas Training and Research Hospital between September 1, ...
Eligibility Criteria
Inclusion
- singleton pregnant women
- woman between the ages of 18-45 years
- woman who gave birth at 34 weeks and above
Exclusion
- Pregnancies with less than 1 hour period between hospitalization and delivery
- Women with placenta previa, invasion anomaly or diagnosis of abruptio placentae
- Women with previous uterine surgery or cesarean section
- Women with a history of thromboembolism
- women with serious illness
Key Trial Info
Start Date :
September 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2022
Estimated Enrollment :
480 Patients enrolled
Trial Details
Trial ID
NCT05429580
Start Date
September 1 2021
End Date
February 28 2022
Last Update
December 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nefise Nazlı YENIGUL
Bursa, Turkey (Türkiye), 16110